Table 2 of
Levkovitch-Verbin, Mol Vis 2013; 19:2011-2022. Table 2 of
Levkovitch-Verbin, Mol Vis 2013; 19:2011-2022.
Table 2. Summary of fold regulation change following glaucoma induction
| Symbol | Description | 3 month | 13 month | 18 month | Unigene | Refseq |
|---|---|---|---|---|---|---|
| Aven | Apoptosis, caspase activation inhibitor | 5.37 | -3.19 | −1.31 | Rn.145049 | NM_001107757 |
| Bad | BCL2-associated agonist of cell death | 1.98 | 2.47 | −1.02 | Rn.36696 | NM_022698 |
| Bcl2 | B-cell CLL/lymphoma 2 | 3.46 | 1.45 | 1.14 | Rn.9996 | NM_016993 |
| Bcl2a1d | B-cell leukemia/lymphoma 2 related protein A1d | 1.75 | 1.30 | 2.17 | Rn.19770 | NM_133416 |
| Bcl2l1 | Bcl2-like 1 | 8.35 | -2.38 | −1.12 | Rn.10323 | NM_031535 |
| Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | −1.70 | -2.18 | −1.46 | Rn.82709 | NM_022612 |
| Hrk | Harakiri, BCL2 interacting protein | −1.09 | -2.93 | 1.75 | Rn.89639 | NM_057130 |
| Bik | BCL2-interacting killer (apoptosis-inducing) | 2.68 | 1.38 | 1.08 | Rn.38487 | NM_053704 |
| Naip2 | NLR family, apoptosis inhibitory protein 2 | 2.91 | 1.14 | 2.48 | Rn.92423 | XM_226742 |
| Birc3 | Baculoviral IAP repeat-containing 3 | −1.58 | -3.64 | -2.08 | Rn.64578 | NM_023987 |
| Card6 | Caspase recruitment domain family, member 6 | 1.67 | -2.14 | −1.25 | Rn.104526 | NM_001106413 |
| Casp1 | Caspase 1 | 1.61 | -2.90 | 2.03 | Rn.37508 | NM_012762 |
| Casp4 | Caspase 4, apoptosis-related cysteine peptidase | 11.18 | 2.03 | 2.96 | Rn.16195 | NM_053736 |
| Casp12 | Caspase 12 | -2.40 | 2.35 | 1.54 | Rn.81078 | NM_130422 |
| Casp14 | Caspase 14 | -2.40 | -3.20 | −1.24 | Rn.198773 | XM_234878 |
| Casp6 | Caspase 6 | 6.67 | 1.78 | 1.13 | Rn.88160 | NM_031775 |
| Casp7 | Caspase 7 | 2.11 | -3.28 | −1.70 | Rn.53995 | NM_022260 |
| Casp8 | Caspase 8 | 1.00 | −1.10 | 1.55 | Rn.54474 | NM_022277 |
| Casp8ap2 | Caspase 8 associated protein 2 | -2.04 | -3.45 | −1.56 | Rn.198715 | XM_232860 |
| Cideb | Cell death-inducing DFFA-like effector b | -2.40 | −1.71 | −1.00 | Rn.204016 | NM_001108869 |
| Dapk1 | Death associated protein kinase 1 | 3.31 | -2.52 | −1.46 | Rn.23108 | NM_001107335 |
| Dffa | DNA fragmentation factor, alpha subunit | 2.02 | -2.17 | −1.92 | Rn.6514 | NM_053679 |
| Dffb | DNA fragmentation factor, beta polypeptide (caspase-activated DNase) | -2.40 | -9.22 | -3.57 | Rn.67077 | NM_053362 |
| Fadd | Fas (TNFRSF6)-associated via death domain | 1.80 | -2.21 | 1.13 | Rn.16183 | NM_152937 |
| Faim | Fas apoptotic inhibitory molecule | 3.29 | -2.65 | 1.14 | Rn.106419 | NM_080895 |
| Il10 | Interleukin 10 | -2.40 | 1.65 | 3.63 | Rn.9868 | NM_012854 |
| Lhx4 | LIM homeobox 4 | 1.60 | -4.09 | −1.12 | Rn.48080 | NM_001108348 |
| Lta | Lymphotoxin alpha (TNF superfamily, member 1) | -2.40 | −1.64 | 4.12 | Rn.160577 | NM_080769 |
| Ltbr | Lymphotoxin beta receptor (TNFR superfamily, member3) | 3.12 | 8.95 | 1.69 | Rn.19329 | NM_001008315 |
| Nfkb1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 3.31 | -2.07 | 0.73 | Rn.2411 | XM_342346 |
| Nol3 | Nucleolar protein 3 (apoptosis repressor with CARD domain) | 2.12 | 2.08 | 1.21 | Rn.86956 | NM_053516 |
| Polb | Polymerase (DNA directed), beta | 1.41 | -3.24 | −1.23 | Rn.9346 | NM_017141 |
| Prdx2 | Peroxiredoxin 2 | 2.05 | 2.92 | 1.00 | Rn.2511 | NM_017169 |
| Prlr | Prolactin receptor | -2.40 | 1.50 | 1.06 | Rn.9757 | NM_012630 |
| Prok2 | Prokineticin 2 | -2.40 | 1.63 | 4.20 | Rn.211872 | NM_138852 |
| Pycard | PYD and CARD domain containing | 2.58 | -4.96 | 1.69 | Rn.7817 | NM_172322 |
| Sphk2 | Sphingosine kinase 2 | -2.16 | -2.98 | 1.01 | Rn.41053 | NM_001012066 |
| Tnf | Tumor necrosis factor (TNF superfamily, member 2) | 2.40 | 2.37 | 2.28 | Rn.2275 | NM_012675 |
| Tnfrsf10b | Tumor necrosis factor receptor superfamily, member 10b | -2.01 | -2.83 | −1.22 | Rn.105558 | NM_001108873 |
| Tnfrsf11b | Tumor necrosis factor receptor superfamily, member 11b | -2.40 | 3.43 | −1.44 | Rn.202973 | NM_012870 |
| Tnfrsf1a | Tumor necrosis factor receptor superfamily, member 1a | 4.08 | −1.59 | 2.18 | Rn.11119 | NM_013091 |
| Tnfrsf1b | Tumor necrosis factor receptor superfamily, member 1b | 3.08 | -2.11 | −1.01 | Rn.83633 | NM_130426 |
| Cd40 | CD40 molecule, TNF receptor superfamily member 5 | 1.31 | 1.69 | 3.81 | Rn.25180 | NM_134360 |
| Fas | Fas (TNF receptor superfamily, member 6) | 1.20 | 2.21 | −1.16 | Rn.162521 | NM_139194 |
| Tnfsf10 | Tumor necrosis factor (ligand) superfamily, member 10 | 1.84 | 2.19 | -2.22 | Rn.83627 | NM_145681 |
| Tp53 | Tumor protein p53 | −1.13 | −1.29 | -2.44 | Rn.54443 | NM_030989 |
| Tradd | TNFRSF1A-associated via death domain | 1.58 | -2.52 | 1.45 | Rn.18545 | NM_001100480 |
| LOC687813 | Similar to Tnf receptor-associated factor 1 | -2.40 | -10.10 | −1.27 | Rn.136874 | XM_001080233 |
| Traf3 | Tnf receptor-associated factor 3 | 1.22 | -2.51 | −1.09 | Rn.12033 | NM_001108724 |
| Traf4 | Tnf receptor associated factor 4 | 5.03 | -2.22 | −1.26 | Rn.3219 | NM_001107017 |
| Tp53bp2 | Tumor protein p53 binding protein, 2 | 2.81 | -2.61 | 1.07 | Rn.50333 | XM_223012 |
| Tp63 | Tumor protein p63 | -2.40 | -2.78 | 3.88 | Rn.42907 | NM_019221 |
| Tp73 | Tumor protein p73 | -2.40 | 1.17 | 2.21 | Rn.103860 | NM_001108696 |